PURPLE BIOTECH LTD.
Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.
PPBT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74638P1093 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 4 OPPENHEIMER STREET, 7670104 REHOVOT
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Purple Biotech Ltd. is a clinical-stage company developing first-in-class therapies designed to overcome tumor immune evasion and drug resistance. The company's core strategy involves harnessing the tumor microenvironment (TME) to develop effective and durable treatments. By focusing on novel therapeutic mechanisms, Purple Biotech aims to improve clinical outcomes for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PURPLE BIOTECH LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PURPLE BIOTECH LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PURPLE BIOTECH LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
